Literature DB >> 10975852

Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils.

R G Sitrin1, P M Pan, H A Harper, R F Todd, D M Harsh, R A Blackwood.   

Abstract

Leukocytes use urokinase receptors (uPAR; CD87) in adhesion, migration, and proteolysis of matrix proteins. Typically, uPAR clusters at cell-substratum interfaces, at focal adhesions, and at the leading edges of migrating cells. This study was undertaken to determine whether uPAR clustering mediates activation signaling in human polymorphonuclear neutrophils. Cells were labeled with fluo-3/AM to quantitate intracellular Ca2+ ([Ca2+]i) by spectrofluorometry, and uPAR was aggregated by Ab cross-linking. Aggregating uPAR induced a highly reproducible increase in [Ca2+]i (baseline to peak) of 295 +/- 37 nM (p = 0.0002). Acutely treating cells with high m.w. urokinase (HMW-uPA; 4000 IU/ml) produced a response of similar magnitude but far shorter duration. Selectively aggregating uPA-occupied uPAR produced smaller increases in [Ca2+]i, but saturating uPAR with HMW-uPA increased the response to approximate that of uPAR cross-linking. Cross-linking uPAR induced rapid and significant increases in membrane expression of CD11b and increased degranulation (release of beta-glucuronidase and lactoferrin) to a significantly greater degree than cross-linking control Abs. The magnitude of degranulation correlated closely with the difference between baseline and peak [Ca2+]i, but was not dependent on the state of uPA occupancy. By contrast, selectively cross-linking uPA-occupied uPAR was capable of directly inducing superoxide release as well as enhancing FMLP-stimulated superoxide release. These results could not be duplicated by preferentially cross-linking unoccupied uPAR. We conclude that uPAR aggregation initiates activation signaling in polymorphonuclear neutrophils through at least two distinct uPA-dependent and uPA-independent pathways, increasing their proinflammatory potency (degranulation and oxidant release) and altering expression of CD11b/CD18 to favor a firmly adherent phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975852     DOI: 10.4049/jimmunol.165.6.3341

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.

Authors:  Sai Duriseti; David H Goetz; Daniel R Hostetter; Aaron M LeBeau; Ying Wei; Charles S Craik
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.

Authors:  Anne M Brooks; Mary Ellen Bates; Rose F Vrtis; Nizar N Jarjour; Paul J Bertics; Julie B Sedgwick
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-25       Impact factor: 6.914

3.  Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.

Authors:  Fang Wu; Marcela Catano; Ramiro Echeverry; Enrique Torre; Woldeab B Haile; Jie An; Changhua Chen; Lihong Cheng; Andrew Nicholson; Frank C Tong; Jaekeun Park; Manuel Yepes
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

Review 4.  Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing.

Authors:  Aman Opneja; Sargam Kapoor; Evi X Stavrou
Journal:  Thromb Res       Date:  2019-05-02       Impact factor: 3.944

5.  The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

Authors:  M Resnati; I Pallavicini; J M Wang; J Oppenheim; C N Serhan; M Romano; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 6.  Interactions of integrins with their partner proteins in leukocyte membranes.

Authors:  Howard R Petty; Randall G Worth; Robert F Todd
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

7.  Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block.

Authors:  Paraskevi Briassouli; Elena V Komissarova; Robert M Clancy; Jill P Buyon
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

Review 8.  Serine proteases, inhibitors and receptors in renal fibrosis.

Authors:  Allison A Eddy
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

9.  The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system.

Authors:  James L Coleman; Jorge L Benach
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.

Authors:  Manolis C Demetriou; Michael E Pennington; Raymond B Nagle; Anne E Cress
Journal:  Exp Cell Res       Date:  2004-04-01       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.